High expression of Wnt antagonists (i.e., sclerostin and DKK-1) has been detected in cancer patients with bone involvement and mouse models of cancer in bone [49,100,102,106,107,108], suggesting osteocyte production of these factors is affected by cancer cells in bone. Here, SOST is linked to cancer.